On behalf of Johnson & Johnson, we have exciting organizational news to share, which will continue to help advance our mission to enable a healthier future for patients. Celine Martin has recently been appointed to the new role of Company Group Chairman, Cardiovascular & Specialty Solutions (CSS) Group.
In this role, Celine will have full accountability for Johnson & Johnson’s Acclarent, Biosense Webster, Cerenovus and Mentor organizations, representing about $5 billion in annual sales and over 9,000 employees. Collectively, these businesses help over one million patients each year.
“Celine’s strategic leadership, laser focus on value creation, closeness with our customers, and passion for driving impactful patient outcomes have been cornerstones of her broad-based expertise and will enhance CSS’ future success,” said Ashley McEvoy, Executive Vice President and Worldwide Chairman of Medical Devices.
During her career at Johnson & Johnson, Celine most recently led the Robotics & Digital Solutions (RAD) Group for three years; a multi-organization integration of Auris Health and Verb Surgical in 2020, enabling the practice to continue advancing unprecedented robotics and digital innovation while navigating the challenges of the COVID-19 pandemic. Prior to her role at RAD, she spent 20 years in leadership positions across CSS. She also led Ethicon’s global Endomechanical and Energy businesses, driving growth for industry-leading surgical device and technology portfolios.
